325 related articles for article (PubMed ID: 24591638)
1. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients.
Wu WC; Sun HW; Chen HT; Liang J; Yu XJ; Wu C; Wang Z; Zheng L
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4221-6. PubMed ID: 24591638
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of human hematopoietic stem and progenitor cells in blood using multicolor flow cytometry.
Cimato TR; Furlage RL; Conway A; Wallace PK
Cytometry B Clin Cytom; 2016 Sep; 90(5):415-23. PubMed ID: 26663713
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
[TBL] [Abstract][Full Text] [Related]
4. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
[TBL] [Abstract][Full Text] [Related]
5. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
7. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis.
Kerst JM; Slaper-Cortenbach IC; von dem Borne AE; van der Schoot CE; van Oers RH
Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196
[TBL] [Abstract][Full Text] [Related]
8. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
Zhou Z; French DL; Ma G; Eisenstein S; Chen Y; Divino CM; Keller G; Chen SH; Pan PY
Stem Cells; 2010 Mar; 28(3):620-32. PubMed ID: 20073041
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
10. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood.
Schibler KR; Li Y; Ohls RK; Nye NC; Durham MC; White W; Liechty KW; Le T; Christensen RD
Blood; 1994 Dec; 84(11):3679-84. PubMed ID: 7524747
[TBL] [Abstract][Full Text] [Related]
12. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
[TBL] [Abstract][Full Text] [Related]
13. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
Janowska-Wieczorek A; Marquez LA; Nabholtz JM; Cabuhat ML; Montaño J; Chang H; Rozmus J; Russell JA; Edwards DR; Turner AR
Blood; 1999 May; 93(10):3379-90. PubMed ID: 10233890
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
15. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells.
Xu Y; Liu L; Zhang L; Fu S; Hu Y; Wang Y; Fu H; Wu K; Xiao H; Liu S; Yu X; Zheng W; Feng B; Huang H
PLoS One; 2012; 7(4):e34321. PubMed ID: 22496789
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 is a survival factor for committed myeloid progenitor cells.
Kerst JM; Slaper-Cortenbach IC; van der Schoot CE; Hooibrink B; von dem Borne AE; van Oers RH
Exp Hematol; 1993 Nov; 21(12):1550-7. PubMed ID: 7691639
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus.
Grigoriou M; Banos A; Filia A; Pavlidis P; Giannouli S; Karali V; Nikolopoulos D; Pieta A; Bertsias G; Verginis P; Mitroulis I; Boumpas DT
Ann Rheum Dis; 2020 Feb; 79(2):242-253. PubMed ID: 31780527
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.
Curti A; Fogli M; Ratta M; Tura S; Lemoli RM
J Immunol; 2001 Jan; 166(2):848-54. PubMed ID: 11145659
[TBL] [Abstract][Full Text] [Related]
19. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
Front Immunol; 2019; 10():183. PubMed ID: 30863394
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of receptors for interleukin-3 on subsets of CD34-expressing hematopoietic cells of rhesus monkeys.
Wognum AW; Visser TP; de Jong MO; Egeland T; Wagemaker G
Blood; 1995 Jul; 86(2):581-91. PubMed ID: 7541669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
